Search Details

Word: generic (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...requisite appearance on any list about Harvard nudity. 11) Peter C. “Petros” Shields ’09. The boy can apparently make his body glow. 12) Claude, head of Kirkland maintenance. You can maintain us anytime. 13) Dean Michael D. Smith. You have a generic name and face. You probably also have a generic body, but we’d like to see for ourselves. 14) Michael J. Sandel. Make your case for perfection and make it a good one. 15) Another MIT boy. To make us feel good about ourselves...

Author: By Jessica L. Fleischer, CRIMSON STAFF WRITER | Title: 15 People FM Wants to See Streak at Harvard-Yale | 11/14/2007 | See Source »

...representatives a welcome presence on campus, and do they add something valuable to the undergraduate experiences of their peers?Or can it be that they are simply viewed like the young women handing out gum in front of CVS: faceless figures doing the work of impersonal and (ironically enough) generic brand names, adding to the overly commercial feel of college life? Perhaps this “ridiculously long lasting gum” (the Stride slogan) has finally overstayed its welcome. REPPING THE ‘ASPIRATIONAL’ BRANDHarvard’s campus reps get their jobs in a variety...

Author: By Erin C. Yu, CONTRIBUTING WRITER | Title: What's in a Name? | 11/14/2007 | See Source »

Novartis has since fashioned itself as a health-care company, but its core business, which generated 63% of group sales last year, is branded pharmaceuticals, led by brands such as Diovan and Sandimmun. Vasella leaves the other units--including generic drugs, animal health, Gerber, the eye-care unit CIBA Vision and over-the-counter medicines--in the hands of trusted lieutenants. Novartis announced earlier this year that it will divest the unit that makes foods such as Ovaltine. Some analysts say Novartis could pick up its growth if it got rid of more of its noncore businesses. But Vasella argues...

Author: /time Magazine | Title: Drug Lord | 11/13/2007 | See Source »

Many pharmaceutical firms have drawn criticism for extending their franchises through frivolous lawsuits blocking equivalent generic drugs that are much less expensive. To allow drug companies to recoup investments and collect healthy returns, the Hatch-Waxman Act of 1984 gives companies 20-year monopolies from the day they patent a product. (After that, revenues from a drug can drop as much as 80% within months as generics erode the market.) The law allows drug firms a 30-month monopoly extension to resolve patent disputes. That loophole is much abused. Companies often sue generic manufacturers just to buy time...

Author: /time Magazine | Title: Drug Lord | 11/13/2007 | See Source »

...it’s getting better on the court.” Though the pair will be the focus of opposing squads, they and their coach caution against viewing themselves as an inside-outside duo. The big man-little man combinations like Shaq-Wade that have become a generic recipe for success at the NBA level won’t be the model for this team. “It’s not just two guys,” coach Tommy Amaker says. “I’m more comfortable saying we need multiple players to contribute...

Author: By Lucas A. Paul, CONTRIBUTING WRITER | Title: BASKETBALL '07: More Than Just a 1-2 Punch | 11/13/2007 | See Source »

Previous | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | Next